If you made any changes in Pure these will be visible here soon.

Personal profile

Education

  • 1992 Ph.D., (Pharmacy), Taipei Medical University
  • 1985 M.S., (Pharmacy), Taipei Medical University
  • 1983 B.S., (Pharmacy), Taipei Medical University

Experience

  • 2012 臺北醫學大學藥物科學學科教授
  • 2003-2012 臺北醫學大學藥學系教授

Research Interests

  • Pharmaceutical Analysis
  • Development of biomaterials in drug delivery system

Fingerprint Dive into the research topics where Hsiu-O Ho is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 3 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

開發可遞送粒細胞-巨噬細胞集落刺激因子(GM-CSF)的注射型溫感性水膠載體於癌症免疫療法之應用

Ho, H.

8/1/187/1/19

Project: A - Government Institutionb - Ministry of Science and Technology

以局部控釋傳輸乘載doxorubicin及cisplatin之熱敏感性凝膠作為癌症結合治療應用之研究(3/3)

Ho, H.

8/1/177/31/18

Project: A - Government Institutionb - Ministry of Science and Technology

以局部控釋傳輸乘載doxorubicin及cisplatin之熱敏感性凝膠作為癌症結合治療應用之研究(2/3)

Ho, H.

8/1/167/31/17

Project: A - Government Institutionb - Ministry of Science and Technology

Research Output

  • 2752 Citations
  • 30 h-Index
  • 139 Article
  • 2 Comment/debate
  • 1 Conference contribution
  • 1 Patent

Preparation and characterization of a novel swellable and floating gastroretentive drug delivery system (sfGRDDS) for enhanced oral bioavailability of nilotinib

Lin, H. L., Chen, L. C., Cheng, W. T., Cheng, W. J., Ho, H. O. & Sheu, M. T., Feb 2020, In : Pharmaceutics. 12, 2, 137.

Research output: Contribution to journalArticle

Open Access
  • 1 Citation (Scopus)

    TEMPO-oxidized sacchachitin nanofibers (TOSCNFs) combined with platelet-rich plasma (PRP) for management of dry eye syndrome

    Lin, H. L., Wu, T. H., Ho, H. O., Chao, F. C., Meng-Huang, Liu, W. D. Z., Chen, L. C. & Sheu, M. T., Jan 1 2020, In : International Journal of Nanomedicine. 15, p. 1721-1730 10 p.

    Research output: Contribution to journalArticle

    Open Access
  • In situ chemically crosslinked injectable hydrogels for the subcutaneous delivery of trastuzumab to treat breast cancer

    Lo, Y. W., Sheu, M. T., Chiang, W. H., Chiu, Y. L., Tu, C. M., Wang, W. Y., Wu, M. H., Wang, Y. C., Lu, M. & Ho, H. O., Mar 1 2019, In : Acta Biomaterialia. 86, p. 280-290 11 p.

    Research output: Contribution to journalArticle

  • 4 Citations (Scopus)
  • 7 Citations (Scopus)